Published in J Neuroimmune Pharmacol on March 25, 2010
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev (2011) 1.66
Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer's disease models. Sci Rep (2016) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 14.43
The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci (2009) 3.06
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol (1999) 2.46
Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci (2001) 2.40
A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed (1991) 2.12
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun (2008) 1.92
Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol (2004) 1.89
Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (2003) 1.74
Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem (2005) 1.70
Microglia. Metab Brain Dis (2004) 1.58
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia (2005) 1.49
Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci (2002) 1.43
Microglia: phagocyte and glia cell. Int J Biochem Cell Biol (2005) 1.40
Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J Neurosci (2009) 1.38
Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J Infect Dis (1992) 1.31
Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol (2006) 1.23
Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience (1996) 1.21
Thalidomide inhibits tumor necrosis factor-alpha production by lipopolysaccharide- and lipoarabinomannan-stimulated human microglial cells. J Infect Dis (1995) 1.19
Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis (1997) 1.18
Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages. J Exp Med (1983) 1.16
Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis (1994) 1.13
Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J Immunol (2007) 1.13
Activation of mu opioid receptors inhibits microglial cell chemotaxis. J Pharmacol Exp Ther (1997) 1.12
Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia (1996) 1.09
Anti-inflammatory effects of opioids. Adv Exp Med Biol (2003) 1.06
Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. Life Sci (2008) 1.03
Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity. Brain Res (2008) 1.02
Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol (1995) 0.99
Filamentous actin is concentrated in specific subpopulations of neuronal and glial structures in rat central nervous system. Brain Res (2001) 0.97
Morphine inhibits human microglial cell production of, and migration towards, RANTES. J Psychopharmacol (2000) 0.95
Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro. Clin Diagn Lab Immunol (1995) 0.92
Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev Neurosci (1995) 0.88
Lactate induced excitotoxicity in hippocampal slice cultures. Exp Neurol (2004) 0.81
Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury. Mol Chem Neuropathol (1995) 0.79
The effects of repeated endotoxin exposure on rat brain metabolites as measured by ex vivo 1HMRS. J Neuroimmunol (2005) 0.78
Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev (2009) 1.90
Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol (2005) 1.88
Morphine induces apoptosis of human microglia and neurons. Neuropharmacology (2002) 1.61
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Globalization: a new dimension for academic internal medicine. Am J Med (2006) 1.50
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia (2005) 1.49
Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol (2008) 1.48
Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol (2003) 1.45
Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia (2004) 1.26
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain (2003) 1.25
Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol (2007) 1.24
Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol (2006) 1.23
Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis (2005) 1.20
alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther (2002) 1.20
Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res (2006) 1.18
Differential responses of human brain cells to West Nile virus infection. J Neurovirol (2005) 1.17
Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis (2005) 1.17
Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis. Pharmacol Ther (2009) 1.15
TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. J Leukoc Biol (2005) 1.14
High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res (2004) 1.09
The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception. Pain (2005) 1.09
Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture. Mol Pain (2010) 1.09
Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int Immunopharmacol (2006) 1.08
CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol (2003) 1.08
Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J Neurosci Res (2005) 1.07
Early detection of central nervous system tuberculosis with the gen-probe nucleic Acid amplification assay: utility in an inner city hospital. Clin Infect Dis (2002) 1.05
Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J Neuroinflammation (2011) 1.05
Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation (2010) 1.05
Intracerebral infection with murine cytomegalovirus induces CXCL10 and is restricted by adoptive transfer of splenocytes. J Neurovirol (2004) 1.03
Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg (2009) 1.03
Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord. J Neurosci (2009) 1.02
Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia (2010) 1.02
Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn. J Comp Neurol (2009) 1.02
Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol (2009) 1.02
Murine cytomegalovirus infection of neural stem cells alters neurogenesis in the developing brain. PLoS One (2011) 1.01
Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther (2006) 1.01
Mechanism of cancer pain. Mol Interv (2010) 1.00
Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. Virus Res (2007) 1.00
Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. J Pharmacol Exp Ther (2002) 0.99
Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1. J Neurovirol (2006) 0.99
Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int J Antimicrob Agents (2003) 0.98
Tumor-induced mechanical hyperalgesia involves CGRP receptors and altered innervation and vascularization of DsRed2 fluorescent hindpaw tumors. Pain (2005) 0.97
Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain (2003) 0.97
Activation of spinal microglia in a murine model of peripheral inflammation-induced, long-lasting contralateral allodynia. Neurosci Lett (2008) 0.97
Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells. J Neurosci Res (2009) 0.96
Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia. J Neuroinflammation (2007) 0.96
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol (2006) 0.96
Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ. J Neurovirol (2011) 0.95
Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol (2008) 0.94
U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol (2003) 0.93